1 Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249. 2 韩苏军,张思维,陈万青,等.中国前列腺癌发病现状和流行趋势分析[J].临床肿瘤杂志,2013,18(4):330-334. 3 Nguyen DP,Li J,Tewari AK.Inflammation and prostate cancer:the role of interleukin 6[J].BJU Int,2014,113(6):986-992. 4 Di Francesco S,Tenaglia RL.Obesity,diabetes and aggressive prostate cancer hormone-naive at initial diagnosis[J].Cent European J Urol,2014,66(4):423-427. 5 Bastaros J,Placer J,Celma A,et al.Current significance of the finding of high grade prostatic intraepithelial neoplasia in the prostate biopsy[J].Actas Urol Esp,2014,38(4):270-275. 6 Montironi R,Mazzucchelli R,Lopez-Beltran A,et al.Prostatic intraepithelial neoplasia:its morphological and molecular diagnosis and clinical significance[J].BJU Int,2011,108(9):1394-1401. 7 Lee D,Lee C,Kwon T,et al.Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia[J].Korean J Urol,2015,56(8):565-571. 8 De Nunzio C,Trucchi A,Miano R,et al.The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy[J].J Urology,2009,181(3):1069-1074. 9 Lee MC,Moussa AS,Yu C,et al.Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer[J].J Urology,2010,184(5):1958-1962. 10 Cicione A,Cantiello F,De Nunzio C,et al.Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy:a prospective single cohort study[J].Urol Oncol,2014,32(1):27-31. 11 Heidenreich A,Aus G,Bolla M,et al.EAU guidelines on prostate cancer[J].Actas Urol Esp,2009,33(2):113-126. 12 Adamczyk P,Wolski Z,Butkiewicz R,et al.Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice[J].Cent European J Urol,2014,67(2):136-141. 13 Caruso C,Balistreri CR,Candore G,et al.Polymorphisms of pro-inflammatory genes and prostate cancer risk:a pharmacogenomic approach[J].Cancer Immunol Immun,2009,58(12):1919-1933. 14 De Nunzio C,Kramer G,Marberger M,et al.The controversial relationship between benign prostatic hyperplasia and prostate cancer:the role of inflammation[J].European Urol,2011,60(1):106-117. 15 Putzi MJ,De Marzo AM.Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia[J].Urology,2000,56(5):828-832. 16 MacLennan GT,Eisenberg R,Fleshman RL,et al.The influence of chronic inflammation in prostatic carcinogenesis:a 5-year followup study[J].Urology,2006,176(3):1012-1016. 17 Sfanos KS,De Marzo AM.Prostate cancer and inflammation:the evidence[J].Histopathology,2012,60(1):199-215. |